Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial.
Explore this paper's citation graph
Summary
A new general procedure for treatment assignment is described which concentrates on minimizing imbalance in the distributions of treatment numbers within the levels of each individual prognostic factor.
- Type
- article
- Published
- 1975-03-01
- Cited by
- 2,323
- References
- 1
- OpenAlex
- https://openalex.org/W2000366267
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:12364101
Keywords
Predictability, Selection (genetic algorithm), Randomization, Clinical trial, Computer science
References
Cited by
- Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial.
- Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial
- New designs for phase 2 clinical trials.
- Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer.
- Randomization in controlled clinical trials: why the flip of a coin is so important.
- Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials.
- Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin +/- all-trans retinoic acid +/- granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.
- Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
- Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy
- Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study.
- Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trial.
- A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer.
- Effect of Dietary Protein Content on Weight Gain, Energy Expenditure, and Body Composition During Overeating
- Dynamic randomization and a randomization model for clinical trials data
- Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years
- IMPACT: A Multi-Level Family and School Intervention Targeting Obesity in Urban Youth
- Incidence and remission of type 2 diabetes in relation to degree of obesity at baseline and 2 year weight change: the Swedish Obese Subjects (SOS) study
- Simulation of Various Randomization Strategies for a Clinical Trial in Sickle Cell Disease
- A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031).
- Perceived stress mediates the relationship between mindfulness and negative affect variability: A randomized controlled trial among middle-aged to older adults
Related papers
- Is stock return predictability time-varying?
- Modeling program predictability
- Modeling program predictability
- Modeling program predictability
- Do Lunch or Be Lunch: The Power of Predictability in Creating Your Future
- Beyond the Limits of Predictability in Human Mobility Prediction: Context-Transition Predictability
- Regional contrasting DTR’s predictability over China